Your browser doesn't support javascript.
loading
A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol.
Brown, Emily; Wilton, Moon M; Sprung, Victoria S; Harrold, Joanne A; Halford, Jason C G; Stancak, Andrej; Burgess, Malcolm; Howarth, Elaine; Umpleby, A Margot; Kemp, Graham J; Wilding, John Ph; Cuthbertson, Daniel J.
Afiliación
  • Brown E; Metabolism and Nutrition Research Group, University Hospital Aintree, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK c.e.brown@liverpool.ac.uk.
  • Wilton MM; Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
  • Sprung VS; Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK.
  • Harrold JA; Research Institute for Sport & Exercise Sciences, Liverpool John Moores University, Liverpool, UK.
  • Halford JCG; Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK.
  • Stancak A; School of Psychology, University of Leeds, Leeds, UK.
  • Burgess M; Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK.
  • Howarth E; Department of Cardiology, University Hospital Aintree, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Umpleby AM; Liverpool Clinical Trials Centre, Institute of Population Health, University of Liverpool, Liverpool, Merseyside, UK.
  • Kemp GJ; Department of Nutritional Sciences, University of Surrey, Guildford, UK.
  • Wilding JP; Liverpool Magnetic Resonance Imaging Centre (LiMRIC), University of Liverpool, Liverpool, UK.
  • Cuthbertson DJ; Department of Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
BMJ Open ; 11(7): e045663, 2021 07 20.
Article en En | MEDLINE | ID: mdl-34285005

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials / Guideline / Risk_factors_studies Aspecto: Ethics Límite: Humans Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials / Guideline / Risk_factors_studies Aspecto: Ethics Límite: Humans Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido